Nature Communications (Sep 2022)
Reconstitution of microtubule into GTP-responsive nanocapsules
Abstract
GTP-triggered release from drug carriers has huge potential in cancer therapy but current carriers suffers from off target release due to ATP also acting as a trigger. Here, the authors report on the development of a microtubule capsule which is engineered to be responsive to only GTP not ATP and demonstrate targeted drug delivery.